NASDAQ · MGRX

Mangoceuticals, Inc.

Healthcare · Medical - Healthcare Information Services

$0.21

Down-$0.01 (-5.00%)

Updated Nov 5, 2026, 5:14 AM

SID Score

2.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 12.92M
P/E ratio: -0.66
Dividend yield: 0.00%
52-week range: $0.16 – $1.25
Volume: 149.85K
Avg. volume: 1.42M

Price performance · MGRX

MGRX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

Last close: $0.21
Period change: -53.32%
Period low: $0.21
Period high: $0.44

Daily close

View OHLC price history

MGRX OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Nov 4, 2026	$0.2115	$0.2192	$0.2031	$0.2071	149.85K
Nov 3, 2026	$0.2426	$0.2426	$0.1963	$0.218	852.44K
Nov 2, 2026	$0.2375	$0.2424	$0.2239	$0.228	442.52K
Oct 30, 2026	$0.257	$0.2595	$0.2289	$0.2334	531.82K
Oct 29, 2026	$0.269	$0.27	$0.2426	$0.2543	234.03K
Oct 28, 2026	$0.2493	$0.2648	$0.248	$0.2581	386.5K
Oct 27, 2026	$0.25	$0.26	$0.2178	$0.248	131.28K
Oct 26, 2026	$0.2305	$0.2538	$0.221	$0.2442	325.08K
Oct 23, 2026	$0.2491	$0.2578	$0.231	$0.2318	300.42K
Oct 22, 2026	$0.2964	$0.3051	$0.2355	$0.2443	926.71K
Oct 21, 2026	$0.291	$0.3054	$0.291	$0.2951	76.11K
Oct 20, 2026	$0.29	$0.305	$0.2801	$0.30	178.27K
Oct 19, 2026	$0.2901	$0.309	$0.28	$0.2801	752.72K
Oct 16, 2026	$0.336	$0.345	$0.285	$0.2899	263.75K
Oct 15, 2026	$0.34	$0.3624	$0.32	$0.321	673.3K
Oct 14, 2026	$0.375	$0.3796	$0.3066	$0.3276	683.03K
Oct 13, 2026	$0.3795	$0.3939	$0.3703	$0.3716	299.36K
Oct 12, 2026	$0.4199	$0.4199	$0.3812	$0.3834	454.99K
Oct 9, 2026	$0.4351	$0.4398	$0.41	$0.422	434.06K
Oct 8, 2026	$0.435	$0.46	$0.4228	$0.4324	583.76K
Oct 7, 2026	$0.4326	$0.4782	$0.4302	$0.4437	646.13K

Latest MGRX news

The latest Smart Investors Daily articles mentioning MGRX.

sec filingOct 13, 2026

MANGOCEUTICALS, INC. (MGRX) Reports Material Event to SEC

sec filingJul 6, 2026

MANGOCEUTICALS, INC. (MGRX) Reports Material Event to SEC

Latest MGRX news

The latest Smart Investors Daily articles mentioning MGRX.

MGRX research

Overview

Company profile and research snapshot.

Company profile

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus: —
Average target: —
Implied upside: —
Analysts: —

Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close

Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”), a company focused on developing, marketing and selling health and wellness products through its telemedicine platforms under the MangoRx and PeachesRx brands, today announced the closing of a registered direct offering with a U.S.-based pri

Benzinga · Oct 9, 2026